Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Spora Cayman Holdings Limited currently manages 2 pending office actions in the Chemistry & Materials technology area. These actions are assigned to 2 distinct examiners, both of whom are located within 1 distinct art unit. UTT, ETHAN A is the busiest examiner for the portfolio, with 1 pending office action.
The distribution of 2 pending office actions among 2 distinct examiners means that each examiner is responsible for exactly 1 matter. While the personnel are distinct, the 1 distinct art unit indicates that both applications are being reviewed within the same technical group. To resolve the 2 pending office actions, the applicant must manage 2 separate examiner relationships while maintaining technical consistency within the 1 distinct art unit. This structure requires addressing the specific feedback of each examiner to advance the active matters.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| UTT, ETHAN A | 1 | 47.8% | +41.2% |
| AFREMOVA, VERA | 1 | 50.5% | +29.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18811742 | NANOEMULSIONS FOR INTERNAL HUMECTATION OF MYCELIUM-BASED TEXTILES | UTT, ETHAN A | — |
| 18626313 | MYCOTEXTILES INCLUDING ACTIVATED SCAFFOLDS AND NANO-PARTICLE CROSS-LINKERS AND METHODS OF MAKING THEM | AFREMOVA, VERA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18811742 | NANOEMULSIONS FOR INTERNAL HUMECTATION OF MYCELIUM-BASED TEXTILES | UTT, ETHAN A | — |
| 18626313 | MYCOTEXTILES INCLUDING ACTIVATED SCAFFOLDS AND NANO-PARTICLE CROSS-LINKERS AND METHODS OF MAKING THEM | AFREMOVA, VERA | — |
| Art Unit | Apps |
|---|---|
| 1783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18811742 | NANOEMULSIONS FOR INTERNAL HUMECTATION OF MYCELIUM-BASED TEXTILES | UTT, ETHAN A | — | §102§103§112 | Non-Final OA | — | Pending | Aug 21, 2024 |
| 18626313 | MYCOTEXTILES INCLUDING ACTIVATED SCAFFOLDS AND NANO-PARTICLE CROSS-LINKERS AND METHODS OF MAKING THEM | AFREMOVA, VERA | 1783 | §102§103§112 | Non-Final OA | — | Pending | Apr 03, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial